The current SGMO market cap is 115.39M. The company's latest EPS is USD -1.0747 and P/E is -0.62.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 26.46M | 27.23M | 157.96M | 6.84M | 9.4M |
Operating Income | -54.89M | -55.39M | 38.47M | -123.57M | -61.61M |
Net Income | -53.16M | -51.97M | 21.13M | -114.51M | -104.16M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 84.45M | 102.43M | 118.19M | 110.7M | 111.3M |
Operating Income | -77.15M | -105.18M | -129.55M | -183.34M | -201.28M |
Net Income | -68.33M | -95.19M | -121M | -178.29M | -192.28M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 593.91M | 562.51M | 440.57M | 325.07M | 219.7M |
Total Liabilities | 284.76M | 267.55M | 104.96M | 91.43M | 84.78M |
Total Equity | 309.15M | 294.96M | 335.61M | 233.64M | 134.92M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 590.4M | 637.52M | 938.55M | 721.92M | 562.51M |
Total Liabilities | 223.14M | 204.78M | 441.18M | 346.58M | 267.55M |
Total Equity | 367.26M | 432.74M | 497.37M | 375.34M | 294.96M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -166.58M | -223.63M | -66.3M | -127.01M | -174.3M |
Investing | 16.67M | 59.29M | 35.73M | 78.2M | 115.82M |
Financing | 65.13M | 84.66M | 8M | 14.52M | 14.42M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 37.15M | -144.4M | 169.88M | -233.25M | -223.63M |
Investing | -178.11M | -59.8M | -271.63M | 248.2M | 59.29M |
Financing | 231.71M | 142.03M | 153.1M | 32.86M | 84.66M |
Market Cap | 115.39M |
Price to Earnings Ratio | -0.62 |
Price to Sales Ratio | 1.08 |
Price to Cash Ratio | 1.19 |
Price to Book Ratio | 0.41 |
Dividend Yield | - |
Shares Outstanding | 178.91M |
Average Volume (1 week) | 3.38M |
Average Volume (1 Month) | 2.3M |
52 Week Change | -62.93% |
52 Week High | 1.8199 |
52 Week Low | 0.2911 |
Spread (Intraday) | 0.01 (1.5%) |
Company Name | Sangamo Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.sangamo.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.